AI assistant
Sending…
CONMED Corp — Director's Dealing 2012
Apr 16, 2012
31971_dirs_2012-04-16_0f506b65-d4f5-423a-b22f-d0fdb5be995e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-04-12
Reporting Person: CORASANTI JOSEPH J (President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-04-12 | Common Stock | M | 8568 | $17.74 | Acquired | 85729 | Direct |
| 2012-04-12 | Common Stock | S | 8568 | $29.30 | Disposed | 77161 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-04-12 | Options To Purchase Common Stock | $17.74 | M | 8568 | Disposed | 2013-05-20 | Common Stock (8568) | Direct |
Footnotes
F1: 5 year vesting schedule, 20% vest each year starting 5/20/2004.
F2: The sales reported in this form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2012.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7